Review article: chronic hepatitis B – anti‐viral or immunomodulatory therapy?
Rijckborst, V., Sonneveld, M. J., Janssen, H. L. A.
Published in Alimentary pharmacology & therapeutics (01.03.2011)
Published in Alimentary pharmacology & therapeutics (01.03.2011)
Get full text
Journal Article
Loss of intrahepatic HBsAg expression predicts sustained response to peginterferon and is reflected by pronounced serum HBsAg decline
Arends, P., Rijckborst, V., Zondervan, P. E., Buster, E., Cakaloglu, Y., Ferenci, P., Tabak, F., Akarca, U. S., Simon, K., Sonneveld, M. J., Hansen, B. E., Janssen, H. L. A.
Published in Journal of viral hepatitis (01.12.2014)
Published in Journal of viral hepatitis (01.12.2014)
Get full text
Journal Article
54 PRESENCE OF ONLY WILDTYPE VIRUS IS THE STRONGEST DETERMINANT OF HBVDNA UNDETECTABILITY AND HBSAG CLEARANCE IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON
Sonneveld, M.J, Rijckborst, V, Zeuzem, S, Heathcote, E.J, Simon, K, Senturk, H, Pas, S.D, Hansen, B.E, Janssen, H.L
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
753 BASELINE HBsAg PREDICTS HBsAg LOSS AFTER 2 YEARS OF TREATMENT-FREE FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH PEGINTERFERON alfa-2a AND ADEFOVIR
Jansen, L, Takkenberg, R.B, de Niet, A, Zaaijer, H.L, Weegink, C.J, Terpstra, V, Dijkgraaf, M.G.W, Molenkamp, R, Janssen, P.L.M, Koot, M, Rijckborst, V, Janssen, H.L.A, Beld, M.G.H.M, Reesink, H.W
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
750 A COMPARISON OF TWO ASSAYS FOR QUANTIFICATION OF HEPATITIS B SURFACE ANTIGEN IN SERUM OF PATIENTS WITH CHRONIC HEPATITIS B
Sonneveld, M.J, Rijckborst, V, Boucher, C.A.B, Zwang, L, Beersma, M.F.C, Hansen, B.E, Janssen, H.L.A
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
737 POLYMORPHISMS NEAR THE IL28B GENE ARE NOT ASSOCIATED WITH RESPONSE TO PEGINTERFERON IN HBeAg-NEGATIVE CHRONIC HEPATITIS B PATIENTS
Brouwer, W.P, Arends, P, Rijckborst, V, ter Borg, M.J, Cakaloglu, Y, Ferenci, P, Tabak, F, Akdogan, M, Simon, K, Raptopoulou-Gigi, M, Örmeci, N, Akarca, U.S, Flisiak, R, Hansen, B, Boonstra, A, Janssen, H.L.A
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
8 EARLY PREDICTION OF SUSTAINED RESPONSE TO PEGINTERFERON ALFA-2A IN HBEAG-NEGATIVE PATIENTS: THE ROLE OF ON-TREATMENT HBSAG AND HBV DNA LEVELS
Rijckborst, V, Hansen, B.E, Cakaloglu, Y, Ferenci, P, Tabak, F, Akdogan, M, Simon, K, Akarca, U.S, Flisiak, R, Verhey, E, van Vuuren, A.J, Boucher, C.A.B, ter Borg, M.J, Janssen, H.L.A
Published in Journal of hepatology (2010)
Published in Journal of hepatology (2010)
Get full text
Journal Article
HBV RNA in serum is an early predictor for sustained immune control following treatment with pegylated interferon alfa in patients with HBeAg negative chronic hepatitis B
Farag, M., Campenhout, M.V., van Boemmel, F., Rijckborst, V., Cakaloglu, Y., Ferenci, P., Tabak, F., Feld, J., Hansen, B., Janssen, H.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
FRI-329 - HBV RNA in serum is an early predictor for sustained immune control following treatment with pegylated interferon alfa in patients with HBeAg negative chronic hepatitis B
Farag, M., Campenhout, M.V., van Boemmel, F., Rijckborst, V., Cakaloglu, Y., Ferenci, P., Tabak, F., Feld, J., Hansen, B., Janssen, H.
Published in Journal of hepatology (01.04.2018)
Published in Journal of hepatology (01.04.2018)
Get full text
Journal Article
Long-Term Outcomes of Ruptured Hepatocellular Carcinoma: An International Multicentric Propensity Score-Matched Study
Joliat, G.-R., de Man, R., Rijckborst, V., Cimino, M., Torzilli, G., Choi, G.H., Lee, H.S., Goh, B., Kokudo, T., Shirata, C., Hasegawa, K., Nishioka, Y., Vauthey, J.-N., Baimas-George, M., Vrochides, D., Demartines, N., Halkic, N., Labgaa, I.
Published in HPB (Oxford, England) (2022)
Published in HPB (Oxford, England) (2022)
Get full text
Journal Article
FRI-157 - Clinical evaluation of hepatitis B core-related antigen monitoring during peginterferon alfa treatment for HBeAg-negative chronic hepatitis B
van Campenhout, M.J., van Oord, G.W., Rijckborst, V., Brouwer, W.P., Ferenci, P., Tabak, F., Akdogan, M., Pinarbasi, B., Simon, K., Raptopoulou-Gigi, M., de Knegt, R.J., Boonstra, A., Janssen, H.L., Hansen, B.E.
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
Loss of intrahepatic HB s A g expression predicts sustained response to peginterferon and is reflected by pronounced serum HB s A g decline
Arends, P., Rijckborst, V., Zondervan, P. E., Buster, E., Cakaloglu, Y., Ferenci, P., Tabak, F., Akarca, U. S., Simon, K., Sonneveld, M. J., Hansen, B. E., Janssen, H. L. A.
Published in Journal of viral hepatitis (01.12.2014)
Published in Journal of viral hepatitis (01.12.2014)
Get full text
Journal Article
Durable hepatitis B surface antigen decline in hepatitis B e antigen-positive chronic hepatitis B patients treated with pegylated interferon-a2b: relation to response and HBV genotype
Sonneveld, MJ, Rijckborst, V, Cakaloglu, Y, Simon, K, Heathcote, E J, Tabak, F, Mach, T, Boucher, CAB, Hansen, B E, Zeuzem, S, Janssen, HLA
Published in Antiviral therapy (01.01.2012)
Published in Antiviral therapy (01.01.2012)
Get full text
Journal Article